Plantibodies' platform allows to orally deliver any biologics to the colon, ranging from small peptides to mAbs.

We are actively seeking strategic partnerships to:

• Co-develop oral versions of partner biologics
• Demonstrate differentiated delivery for gut-localized indications
• Expand pipelines with non-systemic, oral assets

Our modular platform can be applied to existing approved biologics or pipeline candidates, enabling rapid validation and derisked development.

Plantibodies’ Unique Advantages:

• A novel single step process of combining biologics manufacturing & encapsulation for oral administration and colonic release
• Final formulation contains only naturally occurring polymers, which forms a protective shell around the active biologics (no additional chemical coating or nanoparticle required).
• The final product prevents aggregation and precipitation of biologics, for increased activity.
• These advantages can be extended to a range of small peptides (<20kDa) to macromolecules (IgG, IgA - 250kDa) to target the GI.

Let’s Talk

If you're thinking about oral delivery, we're the team that can make it happen — safely, scalably, and precisely where it matters. Let’s accelerate your path together.

📩 email us directly: pierre.bauer@plantibodies.tech